The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Letter to the EditorFull Access

48,XXYY Syndrome, Mood Disorder, and Aggression

To the Editor: A man with 48,XXYY syndrome was evaluated for suicidal and aggressive behavior. This unusual syndrome alerted our service to the associated psychopathology in this genetic disorder.

Mr. A, a 24-year-old man with a documented chromosomal abnormality of 48,XXYY evaluated by a standard cytogenetics technique, was admitted to the hospital for suicidal ideation and aggressive behavior toward his brother, whom he pushed down the stairs. He endorsed symptoms suggestive of a mixed bipolar episode before admission. He appeared to have borderline intelligence, with a documented IQ of 70–80, and was able to finish high school. There was no family history of psychiatric or genetic disorders. His physical appearance was notable for a tall stature, gynecomastia, and truncal obesity. His mental status examination was significant for irritability and a labile, intense affect. His cognition was intact. He had minimal insight into his illness.

Upon admission, Mr. A was given olanzapine and was later switched to oxcarbazepine and citalopram. Provisional diagnoses of bipolar disorder, not otherwise specified, and cluster B personality traits were made. Mr. A was initially uncooperative and frequently became agitated. Toward the end of admission, Mr. A seemed to respond to oxcarbazepine. His mood and behavior improved. He was discharged after 10 days of hospitalization with oxcarbazepine, 1200 mg/day, and citalopram, 40 mg/day.

48,XXYY syndrome was initially considered a variant of Klinefelter’s syndrome (1). Nowadays, it is accepted as a distinct clinical and genetic entity (2, 3). Individuals with this syndrome are more aggressive, more intellectually handicapped, and taller than people with Klinefelter’s syndrome (4). Children and adolescents with 48,XXYY syndrome often come to psychiatrists for behavioral problems, sometimes even before the chromosomal diagnosis is made. The incidences among newborn and institutionalized mentally retarded patients are 1/50,000 and 0.08%–0.33%, respectively (5, 6). Behavioral and intellectual disturbances in these patients are likely related to sex-chromosomal abnormalities (3). Clinical signs of 48,XXYY are generally nonspecific. Some of the common features include tall stature, gynecomastia, truncal obesity, skin ulcers, and a craniofacial dysmorphism described as a “pugilistic” facial appearance (7).

To our knowledge, there are no reports of using psychotropics specifically to treat behavioral problems in this patient population.

References

1. Muldal S, Ockey CH: The “double male”: a new chromosome constitution in Klinefelter’s syndrome. Lancet 1960; 2:492–493CrossrefGoogle Scholar

2. Demirhan O: Clinical findings and phenotype in a toddler with 48,XXYY syndrome (letter). Am J Med Genet A 2003; 119:393–394CrossrefGoogle Scholar

3. Cammarata M, Di Simone P, Graziano L, Giuffre M, Corsello G, Garofalo G: Rare sex chromosome aneuploidies in humans: report of six patients with 48,XXYY, 49,XXXXY, and 48,XXXX karyotypes. Am J Med Genet 1999; 85:86–87Crossref, MedlineGoogle Scholar

4. Parker CE, Mavalwala J, Melnyk J, Fish CH: The 48,XXYY syndrome. Am J Med 1970; 48:777–781Crossref, MedlineGoogle Scholar

5. Maclean N, Mitchell JM: A survey of sex-chromosome abnormalities among 4,514 mental defectives. Lancet 1962; 1:293–296Crossref, MedlineGoogle Scholar

6. Sorensen K, Nielsen J, Jacobsen P, Rolle T: The 48,XXYY syndrome. Ment Defic Res 1978; 22:197–205MedlineGoogle Scholar

7. Zelante L, Piemontese MR, Francioli G, Clavano S: Two 48,XXYY patients: clinical, cytogenetic and molecular aspects. Ann Genet 2003; 46:479–481Crossref, MedlineGoogle Scholar